Considerations for RT-qPCR in molecular point of care testing devices

Considerations for RT-qPCR in molecular point of care testing devices

The COVID-19 pandemic has accelerated the uptake of point of care testing (POCT), with simple, user-administered tests becoming commonplace in schools, places of work and people’s homes. Antigen POCT has been pivotal in SARS-CoV-2 detection, particularly where reverse transcription PCR (RT-PCR) cannot be delivered in a timely manner. However, the use of antigen tests isn’t always appropriate due to variable sensitivity. RT-PCR – or RT-qPCR if using real-time detection – offers greater sensitivity and specificity. Leveraging this technology in POCT brings lab quality results to the point of need, providing rapid, accurate and actionable results to clinicians.

Read more

The BiosearchTech Blog

Most popular

Make your diagnostic workflows more adaptable

Posted on Mon, Jun 06, 2022 @ 12:47 PM

Since early 2020, diagnostic laboratories have had to manage patient sample quantities being in a state of flux. Demand ...
Read more

Topics: SARS-CoV-2, Nucleic acid extraction, Disease detection

Pandemic reflections: Adapting to a constant flux in testing priorities

Posted on Tue, Apr 05, 2022 @ 02:55 PM

What’s changed for clinical labs as we enter the third year of COVID-19 testing? COVID-19, the illness caused by ...
Read more

Topics: SARS-CoV-2

Society can’t handle the caveats to each type of COVID-19 test

Posted on Fri, Feb 11, 2022 @ 02:58 PM

But measurement science could help steer us in a better, more informed direction COVID-19 tests can indicate the ...
Read more

Topics: qPCR, SARS-CoV-2

Pandemic reflections: in the face of SARS-CoV-2 variants, COVID-19 testing remains essential

Posted on Tue, Jan 11, 2022 @ 10:00 AM

What’s changed for clinical labs as we enter the third year of COVID-19 testing? COVID-19, the illness caused by ...
Read more

Topics: SARS-CoV-2

Pandemic reflections: unprecedented demand drives COVID-19 test developers to get creative

Posted on Tue, Dec 28, 2021 @ 07:30 AM

What’s changed for clinical labs as we enter the third year of COVID-19 testing? COVID-19, the illness caused by ...
Read more

Topics: SARS-CoV-2

Technical bulletin: Omicron impact on SARS-CoV-2 mutation analysis and investigation

Posted on Thu, Dec 23, 2021 @ 09:45 AM

The emergence of the Omicron lineage has quickly escalated to be a variant of concern by the World Health Organization ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2

Pandemic reflections: the world is short staffed

Posted on Tue, Dec 21, 2021 @ 04:52 PM

What’s changed for clinical labs as we enter the third year of COVID-19 testing?
Read more

Topics: SARS-CoV-2

Ensuring our diagnostic assays detect the Omicron variant

Posted on Thu, Dec 09, 2021 @ 02:24 PM

On 22 November 2021, The Network for Genomics Surveillance in South Africa detected a new SARS-CoV-2 variant, named the ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2

Streamlining diagnostic workflows for common respiratory diseases, such as SARS-CoV-2, influenza and RSV

Posted on Tue, Nov 30, 2021 @ 02:29 PM

A fourth wave of COVID-19 has already emerged in many countries and a newly classified variant of concern, Omicron ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2, Disease detection

Technical bulletin: SARS-CoV-2 mutation analysis and investigation

Posted on Thu, Oct 14, 2021 @ 03:01 PM

SARS-CoV-2 mutations and associated new variants are being reported regularly in the media and scientific literature. ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2

Can COVID-19 testing be made more sustainable during prolonged uncertainty?

Posted on Mon, Sep 27, 2021 @ 12:36 PM

In September 2021, Delta persists as the most prevalent variant worldwide1 due to its high infectivity, causing surges ...
Read more

Topics: Molecular Diagnostics, qPCR, SARS-CoV-2

Tips for early-stage MDx companies launching new tests during COVID-19 times

Posted on Thu, Sep 02, 2021 @ 12:00 PM

The COVID-19 pandemic brought tremendous change to the molecular diagnostics (MDx) industry, delivering opportunities ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2

Wastewater surveillance: a critical tool in pandemic management

Posted on Tue, Aug 31, 2021 @ 07:48 AM

As SARS-CoV-2 variants continue to threaten public health, officials are looking beyond clinical tests to track ...
Read more

Topics: SARS-CoV-2

Technical bulletin: Emerging SARS-CoV-2 mutations and their effect on the immune response

Posted on Wed, Aug 18, 2021 @ 01:45 PM

Emerging SARS-CoV-2 variants of concern and variants of interest are defined by agencies such as the World Health ...
Read more

Topics: SARS-CoV-2

Genomic surveillance: 3 techniques to detect and characterise SARS-CoV-2 variants

Posted on Wed, May 19, 2021 @ 09:34 AM

As the global population gains greater access to vaccines for COVID-19, scientists and health officials continue to ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

How do SARS-CoV-2 variants affect PCR assays for COVID-19 testing?

Posted on Tue, May 04, 2021 @ 09:03 AM

Researchers have identified several variants of SARS-CoV-2 since they sequenced the original viral strain responsible ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2

Building resilience into SARS-CoV-2 testing workflows: considerations for choosing an RNA isolation method

Posted on Wed, Oct 21, 2020 @ 09:00 AM

Clinical and diagnostic labs worldwide are still experiencing supply chain challenges with their SARS-CoV-2 testing ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

Pressing COVID-19 testing issues of today and the near future

Posted on Wed, Aug 26, 2020 @ 07:57 AM

Following up with the panelists from our recent COVID-19 webinar, Part 3 of 3 In the previous two blog posts in this ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

Sensitivity and accuracy in COVID-19 testing

Posted on Wed, Aug 19, 2020 @ 07:56 AM

Following up with the panelists from our recent COVID-19 webinar, Part 2 of 3 In the face of a rapidly evolving ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

Scaling up COVID-19 viral testing

Posted on Wed, Aug 12, 2020 @ 07:47 AM

Following up with the panelists from our recent COVID-19 webinar, Part 1 of 3 The COVID-19 pandemic has presented ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

Enabling a rapid response to COVID-19 by Honeywell and LGC, Biosearch Technologies

Posted on Wed, Jul 29, 2020 @ 12:40 PM

As countries worldwide begin to ease lockdown restrictions during the pandemic and prepare to return to “normal” ...
Read more

Topics: Molecular Diagnostics, Genomics, qPCR, SARS-CoV-2

Robust supply chains and open testing systems: How our AgBio roots meet the FDA's EUA process to enable solutions to the COVID-19 pandemic

Posted on Tue, May 19, 2020 @ 08:18 AM

It may seem strange that a company known for transforming the global seed breeding industry is uniquely positioned to ...
Read more

Topics: Molecular Diagnostics, Genomics, qPCR, SARS-CoV-2

Behind the scenes: How our oligo synthesis team contributes to the reliability of your assays

Posted on Thu, Apr 30, 2020 @ 02:13 PM

We’re not rejecting you, just your oligo PCR is arguably one of the most enabling technologies of modern molecular ...
Read more

Topics: Molecular Diagnostics, Oligo synthesis and modifications, Genomics, SARS-CoV-2

When you don’t need an EUA for SARS-CoV-2 testing

Posted on Fri, Apr 10, 2020 @ 03:00 PM

On March 25, 2020, the US Food and Drug Administration (FDA) held the first of a series of virtual town halls they will ...
Read more

Topics: Molecular Diagnostics, SARS-CoV-2

Addressing COVID-19 together: LGC, Biosearch Technologies and Shanghai Liferiver Biotechnology Co., Ltd.

Posted on Tue, Mar 31, 2020 @ 10:13 AM

In the nearly three months since the first confirmed case of COVID-19, the outbreak has become a global crisis, with ...
Read more

Topics: Molecular Diagnostics, Oligo synthesis and modifications, Genomics, SARS-CoV-2

What diagnostic test makers and CLIA labs in the US need to know about Emergency Use Authorization (EUA)

Posted on Tue, Mar 24, 2020 @ 11:58 AM

*Since the original publication of this blog, LGC, Biosearch Technologies is now the only acceptable commercial ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

Coronavirus outbreak: Collaboration to meet the challenge

Posted on Mon, Mar 16, 2020 @ 12:30 PM

Coronavirus, or COVID-19, is an infectious virus that is spreading rapidly around the world and the World Health ...
Read more

Topics: Molecular Diagnostics, Genomics, SARS-CoV-2

Subscribe to our blog

About LGC, Biosearch Technologies

LGC, Biosearch Technologies is the complete Genomics portfolio from LGC. Providing genomic analysis tools, instrumentation and services to the genomic scientific discovery sector worldwide, with focus on across ag bio, pharma and molecular diagnostics. Visit our home page to view our products and services.

Posts by popularity

Follow @BiosearchTech on Twitter

Become a Fan on Facebook!